Peritoneal dialysis treatment for severe lupus nephritis patients complicated with essential organ dysfunction

Zhou,Yan; Yu,Yusheng; Tang,Zheng; Li,Shijun; Hu,Weixin; Luo,Chunlei; Liu,Zhihong

doi:10.3892/etm.2015.2799

Peritoneal dialysis treatment for severe lupus nephritis patients complicated with essential organ dysfunction

Authors:
- Yan Zhou
- Yusheng Yu
- Zheng Tang
- Shijun Li
- Weixin Hu
- Chunlei Luo
- Zhihong Liu
View Affiliations

Affiliations: Research Institute of Nephrology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu 210002, P.R. China
Published online on: October 14, 2015 https://doi.org/10.3892/etm.2015.2799
Pages: 2253-2258

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to evaluate the clinical efficacy of peritoneal dialysis (PD) in patients with severe lupus nephritis (LN) complicated with organ dysfunction. In total, 13 severe LN patients complicated with multiple‑organ dysfunction, who underwent PD treatment between November 2003 and September 2010, were enrolled in the study. Six patients received methylprednisolone pulse therapy due to lupus activity and progressive renal failure. These patients were complicated with severe edema, cardiac insufficiency and severe hypoalbuminemia. PD was applied to the patients, followed by the administration of immunosuppressants. Patients were followed‑up to review the parameters of renal function, the immunological indexes and the systemic lupus erythematosus disease activity index. The results indicated that the general state of health was markedly improved following PD treatment, with edema abatement and improvement of heart function and physical strength. Serum creatinine levels significantly decreased from 6.3±1.6 to 2.6±1.0 mg/dl. A total of 10 cases ceased PD treatment during the follow‑up, while three cases continued PD to the end of the follow‑up period. The levels of albumin and hemoglobin exhibited a marked increase from 29.7±5.7 to 35.2±5.5 g/l and 8.7±1.8 to 9.8±1.8 g/l, respectively. There was one case of peritonitis, one case of peritoneal leakage and two cases of pneumonia. Therefore, PD may be a successful treatment method for severe LN patients complicated with essential organ dysfunction. PD not only improved the symptoms of edema and heart failure, but also played an important role in preserving residual renal function and improving the nutritional state of the patients. Thus, PD can be considered as a treatment option for patients with severe LN associated with acute kidney injury, however, selecting a suitable immunosuppressant during PD treatment is essential.

View Figures

View References

1	Zhu X, Li F, Yang B, Liang J, Qin H and Xu J: Effects of ultraviolet B exposure on NDA methylation in patients with systemic lupus erythematosus. Exp Ther Med. 5:1219–1225. 2013.PubMed/NCBI
2	Fayaz A, Pirson Y, Cosyns JP, Yango L and Lambert M: Pauci-immune necrotizing and crescentic glomerulonephritis in a patient with systemic lupus erythematosus. Clin Nephrol. 69:290–293. 2008. View Article : Google Scholar : PubMed/NCBI
3	Rao L, Liu G, Li C, Li Y, Wang Z, Zhou Z, Tong S and Wu X: Specificity of anti-SSB as a diagnostic marker for the classification of systemic lupus erythematosus. Exp Ther Med. 5:1710–1714. 2013.PubMed/NCBI
4	Soni S and Saboo S: High-volume peritoneal dialysis in acute kidney injury. Kidney Int. 75:11192009. View Article : Google Scholar : PubMed/NCBI
5	Ren W, Chen W, Pan HX, Lan L, Wang P, Huang YH, Kong M and Wang K: Clinical application of right low-position modified peritoneal dialysis catheterization. Exp Ther Med. 5:457–460. 2013.PubMed/NCBI
6	Rietveld A and Berden JH: Renal replacement therapy in lupus nephritis. Nephrol Dial Transpl. 23:3056–3060. 2008. View Article : Google Scholar
7	Zhang ZY, Zhou CH, Li MX and Yu YW: Long-term efficacy of intermittent peritoneal dialysis using various doses. Exp Ther Med. 3:519–524. 2012.PubMed/NCBI
8	Shaw LM, Nicholls A, Hale M, Armstrong VW, Oellerich M, Yatscoff R, Morris RE, Holt DW, Venkataramanan R, Haley J, Halloran P, Ettenger R, Keown P and Morris RG: Therapeutic monitoring of mycophenolic acid. A consensus panel report. Clin Biochem. 31:317–322. 1998. View Article : Google Scholar : PubMed/NCBI
9	Wang A, Wang Y, Wang G, Zhou Z and Yang X: Infective endocarditis associated with acute renal railure: Repeat renal biopsy and successful recovery. Exp Ther Med. 1:433–436. 2010. View Article : Google Scholar : PubMed/NCBI
10	Chionh CY, Ronco C, Finkelstein FO, Soni SS and Cruz DN: Acute peritoneal dialysis: what is the ‘adequate’ dose for acute kidney injury? Nephrol Dial Transplant. 25:3155–3160. 2010. View Article : Google Scholar : PubMed/NCBI
11	Stenvinkel P, Chung SH, Heimbürger O and Lindholm B: Malnutrition, inflammation, and atherosclerosis in peritoneal dialysis patients. Perit Dial Int. 21(Suppl 3): S157–S162. 2001.PubMed/NCBI
12	Li L, Wang R, Shi HH, Xie L, Li JD, Kong WC, Tang JT, Ke DN and Zhao LY: In vitro study on the feasibility of magnetic stent hyperthermia for the treatment of cardiovascular restenosis. Exp Ther Med. 6:347–354. 2013.PubMed/NCBI
13	Takahashi T, Kubota M, Nakamura T, Ebihara I and Koide H: Interleukin-6 gene expression in peripheral blood mononuclear cells from patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis. Ren Fail. 22:345–354. 2000. View Article : Google Scholar : PubMed/NCBI
14	Coplon NS, Diskin CJ, Petersen J and Swenson RS: The long-term clinical course of systemic lupus erythematosus in end-stage renal disease. N Engl J Med. 308:186–190. 1983. View Article : Google Scholar : PubMed/NCBI
15	Cheigh JS and Stenzel KH: End-stage renal disease in systemic lupus erythematosus. Am J Kidney Dis. 21:2–8. 1993. View Article : Google Scholar : PubMed/NCBI
16	Zhou F, Ji J, Song Q, Peng Z, Zhang G and Wang Y: Pulmonary fat embolism and related effects during femoral intramedullary surgery: An experimental study in dogs. Exp Ther Med. 6:469–474. 2013.PubMed/NCBI
17	Gabriel DP, Caramori JT, Martin LC, Barretti P and Balbi AL: Continuous peritoneal dialysis compared with daily hemodialysis in patients with acute kidney injury. Perit Dial Int. 29(Suppl 2): S62–S71. 2009.PubMed/NCBI
18	Rodby RA, Korbet SM and Lewis EJ: Persistence of clinical and serologic activity in patients with systemic lupus erythematosus undergoing peritoneal dialysis. Am J Med. 83:613–618. 1987. View Article : Google Scholar : PubMed/NCBI
19	Altieri P, Sau G, Cao R, Barracca A, Menneas A, Micchittu B, Cabiddu G, Esposito P and Pani A: Immunosuppressive treatment in dialysis patients. Nephrol Dial Transplant. 17(Suppl 8): 2–9. 2002. View Article : Google Scholar : PubMed/NCBI
20	Siu YP, Leung KT, Tong MK, Kwan TH and Mok CC: Clinical outcomes of systemic lupus erythematosus patients undergoing continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 20:2797–2802. 2005. View Article : Google Scholar : PubMed/NCBI
21	Tachaudomdach C, Kantachuvesiri S, Changsirikulchai S, Wimolluck S, Pinpradap K and Kitiyakara C: Connective tissue growth factor gene expression and decline in renal function in lupus nephritis. Exp Ther Med. 3:713–718. 2012.PubMed/NCBI
22	Weng CH, Hsu CW, Yu CC, Yen TH, Yang CW and Hung CC: Peritoneal dialysis and hemodialysis in systemic lupus erythematosus patients: comparison of clinical outcomes. Kidney Blood Press Res. 32:451–456. 2009. View Article : Google Scholar : PubMed/NCBI
23	Liang CC, Huang CC, Wang IK, Chang CT, Chen KH, Weng CH, Lin JL, Hung CC, Yang CW and Yen TH: Impact of renal survival on the course and outcome of systemic lupus erythematosus patients treated with chronic peritoneal dialysis. Ther Apher Dial. 14:35–42. 2010. View Article : Google Scholar : PubMed/NCBI
24	Andrews PA, Warr KJ, Hicks JA and Cameron JS: Impaired outcome of continuous ambulatory peritoneal dialysis in immunosuppressed patients. Nephrol Dial Transplant. 11:1104–1108. 1996. View Article : Google Scholar : PubMed/NCBI
25	Odama UO, Shih DJ and Korbet SM: Sclerosing peritonitis and systemic lupus erythematosus: a report of two cases. Perit Dial Int. 19:160–164. 1999.PubMed/NCBI
26	Szakszon K, Csízy I and Szabó T: Early introduction of peritoneal dialysis may improve survival in severe sepsis. Pediatr Emerg Care. 25:599–602. 2009. View Article : Google Scholar : PubMed/NCBI